However, carriers of variants impairing MT2 signalling demonstrated a nominally significant lower glucose-stimulated insulin response (β −0.47 SD [95% CI −0.82, −0.11]).
← all excerpts
Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA<sub>1c</sub> levels but not with type 2 diabetes.
1
—
—